These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10356917)

  • 1. [Cortexin effectiveness in circulatory encephalopathy].
    Khavinson VKh; Morozov VG; Rybnikov VIu; Zakutskiĭ NG
    Klin Med (Mosk); 1999; 77(4):42-5. PubMed ID: 10356917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of cortexin electrophoresis in the prophylaxis of cerebral strokes].
    Markin SP; Chizhov AIa; Borisov VA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (2):13-5. PubMed ID: 15154345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical manifestations and vascular reactivity in patients with dyscirculatory encephalopathy].
    Maksudov GA; Mashanova GA; Pletneva LV; Babenkova SB; Vlasenko IT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(6):850-6. PubMed ID: 676611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of cortexin on memory and attention].
    Tsyganov VN; Bogoslovskiĭ MM
    Voen Med Zh; 2004 Sep; 325(9):31-5, 80. PubMed ID: 15537099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of cortexin in the complex treatment of patients with chronic alcohol encephalopathy and polyneuropathy].
    Solov'ev AG; Elistratova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):48-51. PubMed ID: 20517210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reflexotherapy and carbon dioxide baths in the complex treatment of patients with circulatory encephalopathy of arteriosclerotic etiology].
    Manucharian GG; Melikian TV; Markosian GK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):60-3. PubMed ID: 1319652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-electroencephalographic characteristics of various stages of dyscirculatory encephalopathy].
    Rukhmanov AA; Zhirmunskaia EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):21-7. PubMed ID: 2718658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of mental function in patients with circulatory encephalopathy due to hypertension and atherosclerosis].
    Voloshin PV; Kryzhenko TV; Mishchenko TS; Shestopalova LF
    Vrach Delo; 1989 Jul; (7):77-80. PubMed ID: 2800511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
    Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
    Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children.
    Spasov AA; Ostrovskij OV; Chernikov MV; Wikman G
    Phytother Res; 2004 Jan; 18(1):47-53. PubMed ID: 14750201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of cortexin in neurological practice for treatment of out-patients with chronic cerebrovascular disturbances].
    Boĭko AN; Batysheva TT; Vinetskiĭ IaIa; Vdovichenko TV; Ganzhula PA; Gaponova OV; Zhuravleva EIu; Ismailov AM; Lisneker LN; Otcheskaia OV; Khozova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):25-30. PubMed ID: 16768221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical efficacy and pharmacoeconomic characteristics of the neuroprotection with low doses of cortexin in the treatment of acute ischemic stroke].
    Aliferova VM; Dadasheva MN; Doronin BM; Kovalenko AV; Lokshtanova TM; Martynov MIu; Meshkova KS; Salimov KA; Stakhovskaia LV; Chefranova ZhIu; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):41-6. PubMed ID: 24874316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity].
    Nurguzhaev ES; Mitrokhin DA; Izbasarova ASh; Nurguzhaev AE; Raimkulov BN; Abdil'manova BR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):66-9. PubMed ID: 19672239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy].
    Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; Shirinskiĭ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of purulent complications in operations on large joints by endolymphatic infusion of drugs].
    Vyrenkov IuE; Dmitriev AE; Murylev VIu; Zorokhovich OL; Shishlo VK; Vtorenko VI
    Khirurgiia (Mosk); 1998; (12):45-7. PubMed ID: 9916435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possibility of treatment of cognitive impairment in the complex therapy of patients with the consequences of cerebral infarction].
    Kuznetsova EB; Salina EA; Sholomov II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):103-106. PubMed ID: 26978058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.